Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × NSCLC × 30 days × Clear all

Phase

Status

Terminated 1 Suspended 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 6 Neoplasm Metastasis 5 Lung Neoplasms 5 Prostatic Neoplasms 4 Leukemia, Myeloid, Acute 4 Breast Neoplasms 4 Triple Negative Breast Neoplasms 3 Myelodysplastic Syndromes 3 Small Cell Lung Carcinoma 2 Sarcoma 2 Ovarian Neoplasms 2 Neoplasm, Residual 2 Multiple Myeloma 2 Lymphoma, Large B-Cell, Diffuse 2 Colonic Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma 2 Breast Carcinoma In Situ 2 Brain Neoplasms 2 Vulvar Neoplasms 1 Urinary Bladder Neoplasms 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Phase 2 Study 1 Peripheral Nervous System Diseases 1 Penile Neoplasms 1 Pancreatic Neoplasms 1

Interventions

HM781-36B 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05378763 2026-02-18

PINNACLE

Spectrum Pharmaceuticals, Inc

Phase 3 Suspended

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡